TrialHuman vaccines & immunotherapeutics2023

Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trial.

Jianmin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.